glutathione bromopyruvic acid conjugate 3-Bromopyruvic (Bromopyruvic acid) | Hexokinase II Inhibitor Conjugation With Glutathione and Mercapturic
Conjugation With Glutathione and Mercapturic Acid Formation Biotransformation of Drugs 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect Induction of Ferroptosis by Dual Targeting pH Responsive Nanomicelles in the Treatment of Tamoxifen Resistant Breast Cancer ACS Applied Nano Materials
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24


